BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16288031)

  • 1. A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer.
    Burger AM; Gao Y; Amemiya Y; Kahn HJ; Kitching R; Yang Y; Sun P; Narod SA; Hanna WM; Seth AK
    Cancer Res; 2005 Nov; 65(22):10401-12. PubMed ID: 16288031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoubiquitination of BCA2 RING E3 ligase regulates its own stability and affects cell migration.
    Amemiya Y; Azmi P; Seth A
    Mol Cancer Res; 2008 Sep; 6(9):1385-96. PubMed ID: 18819927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoubiquitination of feline E3 ubiquitin ligase BCA2.
    Wang W; Qu M; Wang J; Zhang X; Zhang H; Wu J; Yu B; Wu H; Kong W; Yu X
    Gene; 2018 Jan; 638():1-6. PubMed ID: 28964893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel RING E3 ubiquitin ligases in breast cancer.
    Burger A; Amemiya Y; Kitching R; Seth AK
    Neoplasia; 2006 Aug; 8(8):689-95. PubMed ID: 16925951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation.
    Wang Z; Nie Z; Chen W; Zhou Z; Kong Q; Seth AK; Liu R; Chen C
    Neoplasia; 2013 Sep; 15(9):1028-35. PubMed ID: 24027428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of partner proteins on BCA2 RING ligase activity.
    Bacopulos S; Amemiya Y; Yang W; Zubovits J; Burger A; Yaffe M; Seth AK
    BMC Cancer; 2012 Feb; 12():63. PubMed ID: 22315970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer.
    Brahemi G; Kona FR; Fiasella A; Buac D; Soukupová J; Brancale A; Burger AM; Westwell AD
    J Med Chem; 2010 Apr; 53(7):2757-65. PubMed ID: 20222671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor.
    Kona FR; Stark K; Bisoski L; Buac D; Cui Q; Dou QP
    Breast Cancer Res Treat; 2012 Sep; 135(2):495-503. PubMed ID: 22850893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of metformin response by breast cancer associated gene 2.
    Buac D; Kona FR; Seth AK; Dou QP
    Neoplasia; 2013 Dec; 15(12):1379-90. PubMed ID: 24403860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the BCA2 ubiquitin E3 ligase in hormone responsive breast cancer.
    Burger AM; Kona F; Amemiya Y; Gao Y; Bacopulos S; Seth AK
    Open Cancer J; 2010; 3(1):116-123. PubMed ID: 21179390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E3 ubiquitin ligase BCA2 promotes breast cancer stemness by up-regulation of SOX9 by LPS.
    Zheng M; Liu W; Zhang R; Jiang D; Shi Y; Wu Y; Ge F; Chen C
    Int J Biol Sci; 2024; 20(7):2686-2697. PubMed ID: 38725852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNF13: a novel RING-type ubiquitin ligase over-expressed in pancreatic cancer.
    Zhang Q; Meng Y; Zhang L; Chen J; Zhu D
    Cell Res; 2009 Mar; 19(3):348-57. PubMed ID: 18794910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion and diversification of BTL ring-H2 ubiquitin ligases in angiosperms: putative Rabring7/BCA2 orthologs.
    Aguilar-Hernández V; Medina J; Aguilar-Henonin L; Guzmán P
    PLoS One; 2013; 8(8):e72729. PubMed ID: 23951330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer.
    Li Y; Zhou Z; Alimandi M; Chen C
    Oncogene; 2009 Aug; 28(33):2948-58. PubMed ID: 19561640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of RNF126 and BCA2 E3 ubiquitin ligases in DNA damage repair signaling and targeted cancer therapy.
    Zhang R; Liu W; Sun J; Kong Y; Chen C
    Pharmacol Res; 2020 May; 155():104748. PubMed ID: 32147403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. h-Goliath, paralog of GRAIL, is a new E3 ligase protein, expressed in human leukocytes.
    Guais A; Siegrist S; Solhonne B; Jouault H; Guellaën G; Bulle F
    Gene; 2006 Jun; 374():112-20. PubMed ID: 16549277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
    Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
    Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifaceted Roles of the E3 Ubiquitin Ligase RING Finger Protein 115 in Immunity and Diseases.
    Wang MX; Liuyu T; Zhang ZD
    Front Immunol; 2022; 13():936579. PubMed ID: 35844553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.
    Lu Q; Lu D; Shao ZM; Li DQ
    Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-proteasome degradation of serum- and glucocorticoid-regulated kinase-1 (SGK-1) is mediated by the chaperone-dependent E3 ligase CHIP.
    Belova L; Sharma S; Brickley DR; Nicolarsen JR; Patterson C; Conzen SD
    Biochem J; 2006 Dec; 400(2):235-44. PubMed ID: 16895519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.